Millendo Therapeutics, Inc (MLND)

Etorro trading 970x250
Millendo Therapeutics, Inc (MLND) Logo

About Millendo Therapeutics, Inc

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan. Address: 110 Miller Avenue, Ann Arbor, MI, United States, 48104

Millendo Therapeutics, Inc News and around…

Latest news about Millendo Therapeutics, Inc (MLND) common stock and company :

45 Biggest Movers From Yesterday
24 Jun, 2021 FinancialContent

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
23 Jun, 2021 FinancialContent

Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 32.66% to $7.92 during Wednesday's regular session. As of ...

31 Stocks Moving In Wednesday's Mid-Day Session
23 Jun, 2021 FinancialContent

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
23 Jun, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off the day with a look at the pre-market stock market movers for Wednesday with the biggest winners and losers. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

26 Stocks Moving in Wednesday's Pre-Market Session
23 Jun, 2021 FinancialContent

Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
22 Jun, 2021 FinancialContent

Gainers Tenax Therapeutics (NASDAQ:TENX) stock rose 18.42% to $2.25 during Tuesday's after-market session. Tenax Therapeutics's ...

Tempest and Millendo Announce Stockholder Approval of Merger
22 Jun, 2021 FinancialContent

Tempest to Trade on Nasdaq Public Markets Under Ticker “TPST”

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COHR, SNX, PFBI, MLND; Shareholders are Encouraged to Contact the Firm
11 Jun, 2021 FinancialContent
SHAREHOLDER ALERT: WeissLaw LLP Reminds MLND, DISCA, FOE and MSGN Shareholders About Its Ongoing Investigations
09 Jun, 2021 FinancialContent
SHAREHOLDER ALERT: WeissLaw LLP Reminds STAY, MLND, MSGN, and MX Shareholders About Its Ongoing Investigations
02 Jun, 2021 FinancialContent
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FOE, MX, DISCA, MLND; Shareholders are Encouraged to Contact the Firm
25 May, 2021 FinancialContent
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates NUAN, HGV, HRVSF, MLND; Shareholders are Encouraged to Contact the Firm
13 May, 2021 FinancialContent
MILLENDO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MLND and Encourages Investors to Contact the Firm
04 May, 2021 FinancialContent
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
22 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
21 Apr, 2021 FinancialContent

Gainers Alterity Therapeutics (NASDAQ:ATHE) stock rose 23.16% to $1.54 during Wednesday's pre-market session. The ...

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
21 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
20 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Lifshitz Law Firm, P.C. Announces Investigation of AEGN, KSU, LEAF, and MLND
18 Apr, 2021 FinancialContent
Stocks That Hit 52-Week Lows On Friday
16 Apr, 2021 FinancialContent

Before 10 a.m. ET Friday, 62 stocks made new 52-week lows. Significant Points: The largest company by ...

The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
16 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Stocks That Hit 52-Week Lows On Thursday
15 Apr, 2021 FinancialContent

Thursday morning, 11 companies set new 52-week lows. Things to Consider: The largest company by market cap to set a ...

The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
15 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

INVESTIGATION ALERT: Halper Sadeh LLP Investigates TLND, MLND, ORBC, FI; Shareholders are Encouraged to Contact the Firm
14 Apr, 2021 FinancialContent
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
14 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of NTEC, MLND, CTAC, and ATH Mergers
13 Apr, 2021 FinancialContent
Stocks That Hit 52-Week Lows On Tuesday
13 Apr, 2021 FinancialContent

Tuesday morning, 38 companies set new 52-week lows. Key Facts: Viatris (NASDAQ:VTRS) was the largest ...

The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
13 Apr, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Stocks That Hit 52-Week Lows On Monday
12 Apr, 2021 FinancialContent

Before 10 a.m. ET on Monday, 30 stocks hit new 52-week lows. Interesting Highlights: The largest company by market ...

MILLENDO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Millendo Therapeutics, Inc. - MLND
07 Apr, 2021 FinancialContent

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Millendo Therapeutics, Inc. (NasdaqGS: MLND) (“the Company”) with Tempest Therapeutics, Inc. pursuant to which Millendo shareholders are expected to only own approximately 18.5% of the combined company, subject to adjustments. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MLND, KSHB, GNMK, ALXN; Shareholders are Encouraged to Contact the Firm
06 Apr, 2021 FinancialContent

Millendo Therapeutics, Inc (MLND) is a NASDAQ Common Stock listed in , ,

970x250